A case of conjunctival MALT lymphoma: successfully treated with solely extended rituximab therapy
Sign Up to like & getrecommendations! Published in 2018 at "International Ophthalmology"
DOI: 10.1007/s10792-018-0844-z
Abstract: PurposePrimary ocular adnexal lymphomas are cured by radiotherapy; however, complications are frequent and relapses may occur. In this case, we aimed to report the efficacy and safety of extended systemic rituximab (anti-CD 20 monoclonal antibody)… read more here.
Keywords: therapy; malt lymphoma; conjunctival malt; rituximab therapy ... See more keywords
Rituximab for the management of idiopathic membranous nephropathy: a meta-analysis
Sign Up to like & getrecommendations! Published in 2020 at "International Urology and Nephrology"
DOI: 10.1007/s11255-020-02633-5
Abstract: Purpose The aim of this study was to evaluate the efficacy of rituximab therapy in the management of idiopathic membranous nephropathy (IMN). Methods After literature search, data from eligible studies were used to perform random-effects… read more here.
Keywords: management idiopathic; rituximab; proteinuria; idiopathic membranous ... See more keywords
A CASE OF STEROID RESPONSIVE SEVERE PNEUMONIA RELATED TO IMMUNE-LIKE RECONSTITUTION INFLAMMATORY RESPONSE 3 MONTHS AFTER RITUXIMAB THERAPY FOR PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH STREPTOCOCCAL INFECTIONS
Sign Up to like & getrecommendations! Published in 2021 at "Chest"
DOI: 10.1016/j.chest.2021.07.1078
Abstract: TOPIC: Diffuse Lung Disease TYPE: Fellow Case Reports INTRODUCTION: Immune reconstitution inflammatory syndrome (IRIS) has a wide variety of presentations including lung involvement with respiratory failure [1]. While traditionally invoked in AIDS, IRIS is also… read more here.
Keywords: rituximab therapy; reconstitution inflammatory; response; case ... See more keywords
Persisting SARS‐CoV‐2 viremia after rituximab therapy: Two cases with fatal outcome and a review of literature
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Haematology"
DOI: 10.1111/bjh.16896
Abstract: SARS‐CoV‐2 infection can cause severe pneumonia (COVID‐19). There is evidence that patients with comorbidities are at higher risk of a severe disease course. The role of immunosuppression in the disease course is not clear. In… read more here.
Keywords: persisting sars; fatal outcome; two cases; rituximab therapy ... See more keywords
Efficacy of rituximab therapy in children with nephrotic syndrome: a 10-year experience from an Iranian pediatric hospital
Sign Up to like & getrecommendations! Published in 2022 at "BMC Pediatrics"
DOI: 10.1186/s12887-022-03109-4
Abstract: Background There are controversy results in the optimal management of children with steroid-dependent and steroid-resistant nephrotic syndrome (SDNS, SRNS). This study aimed to determine the efficacy and safety of rituximab (RTX) in these pediatric patients.… read more here.
Keywords: efficacy rituximab; nephrotic syndrome; year; sdns srns ... See more keywords
Rituximab therapy in pemphigus and other autoantibody-mediated diseases
Sign Up to like & getrecommendations! Published in 2017 at "F1000Research"
DOI: 10.12688/f1000research.9476.1
Abstract: Rituximab, a monoclonal antibody targeting the B cell marker CD20, was initially approved in 1997 by the United States Food and Drug Administration (FDA) for the treatment of non-Hodgkin lymphoma. Since that time, rituximab has… read more here.
Keywords: mediated diseases; pemphigus autoantibody; autoantibody mediated; rituximab therapy ... See more keywords